Endevica Bio Unveils Promising Phase 2 Trial for Colorectal Cancer Patients Endevica Bio marks a significant milestone in its Phase 2 trial for TCMCB07, a peptide drug aimed at preventing weight loss in cancer patients undergoing chemotherapy.

Endevica Bio Unveils Promising Phase 2 Trial for Colorectal Cancer Patients #United_States #Cancer_Research #Northbrook #Endevica_Bio #TCMCB07

Endevica Bio Begins Phase 2 Trial for Drug Targeting Weight Loss in Cancer Patients Endevica Bio has launched a Phase 2 clinical trial for TCMCB07, a peptide aimed at preventing weight loss in cancer patients undergoing chemotherapy. This is a significant advancement for treatment options.

Endevica Bio Begins Phase 2 Trial for Drug Targeting Weight Loss in Cancer Patients #USA #Endevica_Bio #TCMCB07 #Cancer_Patients #Northbrook,_Illinois